High Prevalence of Epiphora to Aid in Growth of Nasal Lacrimal Stent Market
Nasal lacrimal stent is used in the treatment of trauma, infection, malignancy, thermal injury, chemotherapy, radiation, and iatrogenic causes. Increasing cases of trauma are expected to aid in growth of the nasal lacrimal stent market . According to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S. Increasing geriatric population is also expected to aid in growth of the market. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. In the nasal lacrimal stent market , nasal lacrimal stents are typically classified into bicanalicular stents and monocanalicular stents. Bicanalicular stents can be further divided into Crawford stent, Ritleng Stent, Pigtail/Donut stent, and Kaneka Lacriflow stent and monocanalicular stents can be further divid...